Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profile (PPP), ImpriMed is redefining cancer treatment for pets by predicting drug responses with un... Read more
Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Science, succeeding Matthias Heinzel, who has decided to not renew his contract Danny Bar-Zohar to b... Read more
Illumina, led by CEO Jacob Thaysen, delivered a Q4 revenue of $1.1 billion, reflecting a steady 1% year-over-year increase, while its fiscal 2024 revenue stood at $4.3 billion. Despite macroeconomic challenges, the compa... Read more
AstraZeneca delivered $54.1 billion in total revenue for FY 2024, a 21% increase at constant exchange rates (CER), fueled by strong growth across oncology (+24%), CVRM (+20%), and R&I (+25%). Core EPS rose 19% to $8.21, driven by robust product... Read more
Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare diseases, announced that it has closed on a $600 million senior secured revolving credit facility with a bank syndicate. "Sarepta's financial strength and the pos... Read more
Pfizer Inc. reported robust financial results for the full year 2024, achieving total revenues of $63.6 billion, reflecting a 7% year-over-year operational growth. Notably, when excluding contributions from Paxlovid and Comirnaty, operational reven... Read more
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities in Belgium, Spain, the Netherlands, and Sweden, announced that it has successfully... Read more
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new facility is in addition to its existing 50,000 sq... Read more
© 2025 Biopharma Boardroom. All Rights Reserved.
